Business & regional news

Two data releases at London Valves 2024 build on Evolut’s legacy of valve design and performance: Optimize PRO study demonstrates improved procedure efficiencies and valve performance Pooled...

Additional GI Genius™ units installed at VA facilities, providing enhanced colonoscopy care and advancing AI-powered diagnostics for veterans

Endoflip™ is an advanced diagnostic tool that can help expedite accurate diagnosis of esophageal motility disorders, conditions often missed during endoscopies.^1,2

Collaboration with health technology company Tempus seeks to identify causes for undertreatment of minority patients with heart valve disease who may benefit from minimally invasive therapies

With its Meal Detection Technology™* and autocorrections every 5 minutes, Medtronic is expanding outcomes to populations in Asia and empowering patients to achieve greater glycemic control, especially during mealtimes.

New data from Australia, Japan, India, Singapore, Hong Kong, and South Korea demonstrates the MiniMed™ 780G is driving consistent clinical outcomes in diabetes management.

Comparative data and systematic literature review released at VIVA 2024 show breadth and depth of data supporting atherectomy as a treatment for peripheral arterial disease

Newest-generation Evolut TAVI system builds on its market leading valve performance and durability with enhanced coronary access

Funding to support organisations with a mission to improve health outcomes

The VT research will provide important clinical evidence in an underserved patient population

Survey of 1,000 U.S. surgeons finds digital tech like AI and live streaming crucial to closing surgical care gaps in under-resourced regions.

Global expansion of the Avalus Ultra valve continues in Western Europe while company highlights robust, innovative Cardiac Surgery portfolio at EACTS in Lisbon

Bolsters Medtronic Cardiac Surgery’s comprehensive portfolio of cardiac surgical and respiratory innovation

Company recognized among top 52 global companies making positive social impact through core business strategy

ADAPT-PD trial methods and preliminary data published in npj Parkinson’s disease

Dr. James Porter will represent the company this week — including from the Hugo™ console to perform a live partial nephrectomy — at Europe’s biggest urology conference

Annual award celebrates companies fostering cultures of innovation

State-of-the-art facility based in Singapore aims to accelerate adoption of Robotics and AI across Southeast Asia through training and education, improving access to new healthcare technologies and delivering better care experiences across the region

The company will present clinical evidence in young children, pregnancy and type 2 diabetes*

Post-market data collection will add real-world experience to established safety, efficacy, and efficiency evidence profile

New MRI labeling extends active scan time for Medtronic DBS systems

First ever FDA approval provides more options to meet patients’ personalized needs, including those with Parkinson’s disease

Deal expands Pain Interventions portfolio, now offering both unipedicular and bipedicular vertebral augmentation solutions

New York Valves 2024: Late-breaking data included a SMART Trial secondary analysis showing significantly less bioprosthetic valve dysfunction with Evolut TAV across the entire range of small annulus areas when compared with the Edwards Sapien 3™ TAV platform, and CoreValve-Evolut pooled analysis demonstrating valve performance and durability benefits versus surgery.

Dr. Petrovski’s expertise will further strengthen Medtronic clinical and scientific activities to help people with diabetes live better with technology

Medtronic will present the latest data on its MiniMed™ 780G insulin pump and showcase the company’s latest CareLink™ experience launching globally this month

Medtronic, a global leader in medical technology, announced today that it has received U.S. FDA Breakthrough Device designation for Infuse™ bone graft with an intervertebral fusion device and a...

Offering comprehensive support for precise sub-lobar resection surgeries for patients with early-stage lung cancer, and providing treatment that leads to improvements in patients’ prognosis

The company is pursuing hernia and gynecology indications along with urology as it progresses plans to bring choice in robotic surgery technology and partnership to the U.S. Medtronic, a global...

Preliminary findings of the first and only head-to-head trial comparing standard-of-care CT-guided biopsy with electromagnetic navigation bronchoscopy (ENB) for the diagnosis of lung nodules demonstrate non-inferiority and fewer complications when using ENB

Medtronic has modernized its Reveal LINQ™ Insertable Cardiac Monitor (ICM) with artificial intelligence capabilities to reduce false alerts

Symplicity Spyral is the first renal denervation technology to be approved by the National Medical Products Administration; new, innovative, minimally invasive procedure uses radiofrequency energy to help reduce high blood pressure

Medtronic, the global leader in healthcare technology, today announced the release of important clinical outcomes in two leading transcatheter valve therapies. The results for these studies were...

Study shows the investigational use of the MiniMed™ 780G system improved glycemic control during pregnancy. Medtronic, a global leader in healthcare technology, today announced the results of...

Honorary day celebrates Medtronic roots, 75th anniversary year

Groundbreaking studies in Europe and Singapore demonstrate the Medtronic MiniMed™ 780G system can generate cost-savings for health systems. Medtronic, a global leader in healthcare technology,...

Next-generation Avalus Ultra valve is Medtronic’s most advanced surgical aortic tissue valve built on 10 years of clinical experience with the Avalus™ valve

Patient advocate and youth entrepreneur Grace Bowyer will join company executives, shining light on the critical importance for colon cancer screening

Medtronic today announced it received a license from Health Canada for its Symplicity Spyral™ multi-electrode Renal Denervation (RDN) System. This is indicated for the management of essential...

CRT 2024: Evolut TAVR is a safe, effective, and economically cost-effective treatment option for low-risk severe aortic stenosis patients compared to surgery up to four years

Katie will join colorectal cancer screening advocates and Medtronic leaders in a panel conversation, highlighting new data that reveals a stark gap in colorectal cancer awareness, as well as how AI is making the deadly disease more detectable, preventable

Medtronic, a global leader in medical technology, announced today the launch of the new UNiD™ ePRO service in the United States. This solution will change the way patient outcomes are collected...

Annual list highlights organizations leading the way in business integrity

• MEIC is the largest Research and Development (R&D) center outside the US. for Medtronic
• A 250,000 sq. ft. facility devoted to healthcare technology R&D in Hyderabad.

Doubled probe count enables multi-level spine tumor ablations for increased flexibility and efficiency Medtronic plc, a global leader in healthcare technology, today announced that it has received...

Medtronic will unveil the MiniMed™ 780G system with Simplera Sync™, a new disposable, all-in-one sensor.*

STROKE AF study shows long-term continuous cardiac monitoring delivers strong economic value driven by fewer projected lifetime strokes

FEBRUARY 6, 2024 – Hall of Fame Health and the Cranial and Spinal Technologies business of Medtronic, a global medical technology leader, today are announcing a partnership to advance health...

Physician feedback confirms clinical evidence: safe, efficient, and effective treatment offers most versatile new option for atrial fibrillation

86% of subjects preferred closed-loop SCS in a multicenter, randomized, crossover, single blind study of Medtronic’s investigational closed-loop SCS system at one month

24-month European RCT data demonstrates long-term superiority of DTM™ SCS compared with conventional medical management (CMM) for indicated chronic back pain patients not eligible for spine surgery

The Schwab Foundation for Social Entrepreneurship, a sister organization of the World Economic Forum (WEF), announced at WEF’s annual meeting in Davos today that Ruchika Singhal, president of Medtronic LABS, is the 2024 “Corporate Social Innovator of the Year.”

Strong environmental, social, and governance (ESG) management and performance result in continued inclusion on the Dow Jones Sustainability World Index

The next-generation DBS technology is now available in a rechargeable option

The PenditureTM Left Atrial Appendage (LAA) Exclusion System is
for the exclusion of the LAA in patients undergoing a concomitant cardiac surgery procedure.

Simplicity, efficiency, efficacy with unmatched safety data to set a new standard in catheter ablation

AHA23: Artificial intelligence (AI) applied to LINQ II™ ICMs reduce AF and pause (syncope) false alerts that can save clinics in the U.S. more than 400 hours per year

NOVA Study: On-label, prospective, multicenter, randomized controlled trial compared DTM™ SCS to conventional spinal cord stimulation

New guidelines will expand access to automated insulin delivery technology among wider population.

Next-Gen Evolut FX TAVI system enhances procedure ease-of-use, visualization, and predictability

Data shows the successful performance of the AID algorithm under substantial changes to daily routines and lifestyle, including during Ramadan.

NOTE: McGRATH™ MAC video laryngoscopes purchased directly from Medtronic or via its authorized distributors are not affected by this safety notice.

The company will initiate a phased launch of its disposable Simplera^TM CGM at the meeting, its smallest and most comfortable CGM to-date that’s integrated with the InPen^TM smart insulin pen

The ClosureFast™ catheter update brings new features including lower 6F profile and longer heating element for greater efficiency

• Improved survival with ICD therapy: nearly 25% lower risk of death in indicated patients receiving an ICD vs. no ICD
• ICDs confer additional long-term benefits after initial device replacement

40-site pilot program across US, UK, and Europe aims to introduce cutting edge AI solutions into the clinical environment to improve patient care and efficiency

The average UK surgeon loses four hours a week due to inefficient technology – equal to an entire working month each year. Nearly four in five surgeons say care would be easier to deliver with...

National Kidney Foundation and Medtronic survey found dialysis patients’ top concerns potentially better addressed by minimally invasive AV fistula creation procedures

Newly released guidance affirms safety in use of paclitaxel-coated medical devices in treatment of PAD

An additional 11 million Medicare beneficiaries will now have access to coverage for spinal cord stimulation therapy for the treatment of painful diabetic peripheral neuropathy

Orders will be processed immediately and shipments will start in the coming weeks

Results show that the use of InPen resulted in an increase in Time in Range among those in the studies ​

Together with Kings College Hospital, Medtronic has been awarded £2.5 million of government funding for a large-scale, real-world trial of GI Genius in NHS hospitals around the UK. The...

SCAI 2023 Scientific Sessions: Harmony™ Transcatheter Pulmonary Valve System Demonstrates Strong Clinical and Hemodynamic Outcomes at Two Years

Heart Rhythm 2023: Late-breaking analysis of the PULSED AF Trial reveals first of its kind significant, meaningful quality of life improvements and healthcare utilization benefits of the PulseSelect Pulsed Field Ablation System